Clinical Trial: Kidney Cancer
At the NYU Cancer Institute
Study title: Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
For more information or to enroll, contact: Peggy Reilly, NYU Cancer Institute, at 212-731-5161.
